Status:
UNKNOWN
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
Merck Serono International SA
Conditions:
Pregnancy
Pregnancy Loss
Eligibility:
FEMALE
20-36 years
Phase:
PHASE4
Brief Summary
Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of OHSS.
Detailed Description
Whether pregnancy outcome after GnRH-agonist triggering could be improved by adding luteal recLH support plus progesterone, compared to that observed after ovulation triggering with HCG in GnRH antago...
Eligibility Criteria
Inclusion
- \< 36years,
- single blastocystET,
- FSH \< 12
Exclusion
- endometriosis,
- 3 and 4,
- pco,
- frozen sperm
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00954811
Start Date
September 1 2005
End Date
December 1 2010
Last Update
January 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium, 1090